HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clarisonic Energizes L’Oreal Luxe Sales As Firm Eyes Global Rollout

This article was originally published in The Rose Sheet

Executive Summary

“A kind of miracle,” according to L’Oreal CEO Jean-Paul Agon, Clarisonic grew 61% in the firm’s third quarter, and the brand’s “globalization” is still to come. Lancome also helped to boost sales in the firm’s Luxe division 6.6%, on a like-for-like basis, to roughly €1.4 billion ($1.79 billion) for the quarter.

You may also be interested in...



L’Oreal Powering Down Clarisonic After 16 Years Of Innovation, More Than 15 Million Devices Sold

The decision to close Clarisonic follows a 234m impairment charge recorded in 2016 and comes as L’Oreal faces tough strategic decisions in a global economy ravaged by the COVID-19 crisis.

Home Beauty Devices Receive Praise, But Are Market’s “Best-Kept Secret”

Findings of high satisfaction among at-home beauty-device users, but low awareness among consumers overall, lead Kline & Co. to dub the products “beauty’s best-kept secret.” The global market for home beauty devices grew 20% in 2013, with penetration greatest in China, according to the firm’s report.

Home Beauty Devices Receive Praise, But Are Market’s “Best-Kept Secret”

Findings of high satisfaction among at-home beauty-device users, but low awareness among consumers overall, lead Kline & Co. to dub the products “beauty’s best-kept secret.” The global market for home beauty devices grew 20% in 2013, with penetration greatest in China, according to the firm’s report.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel